Sanofi Sponsored Breakfast Symposia - BR1DGE: From Autoimmunity to Action - Managing Early-stage Type 1 Diabetes
Tracks
Meeting Room 105 & 106
| Thursday, August 20, 2026 |
| 6:30 AM - 8:00 AM |
| Meeting Room 105 & 106 (Level 1) |
Details
Breakfast served from 6:30am
This 60-minute symposium will explore the evolving understanding of early-stage Type 1 Diabetes (T1D), focusing on screening, monitoring, and care pathways before clinical onset.
This session is designed for the care teams involved in managing at-risk individuals.
Learning objectives
• Describe the current staging framework for early type 1 diabetes and its clinical relevance
• Identify individuals at risk of progression who may benefit from structured monitoring
• Apply staging and monitoring concepts to clinical decision-making
Speaker
Prof Sarah Glastras
Endocrinologist
Northern Sydney Endocrine Centre
Welcome & Context
7:00 AM - 7:05 AMBiography
Prof Colin Dayan
Professor of Diabetes and Metabolism
University of Birmingham
T1D Evolution: Foundations to Current Understanding (15 min) – Prof Colin Dayan
7:05 AM - 7:20 AMBiography
Prof John Wentworth
Endocrinologist and Senior Clinical Researcher
Royal Melbourne Hospital / St Vincent's Institute of Medical Research
Redefining Early-Stage T1D: Monitoring & Intervention (15 min) – Prof John Wentworth
7:20 AM - 7:35 AMBiography
John Wentworth is an adult endocrinologist whose research focuses on type 1 diabetes prediction and prevention.
Prof Sarah Glastras
Endocrinologist
Northern Sydney Endocrine Centre
Expert Panel Discussion
7:35 AM - 7:55 AMBiography
